XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   126,474,000      
Beginning balance at Dec. 31, 2022 $ 1,116,589 $ 126 $ 1,244,504 $ (57,488) $ (70,553)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchases of common stock (in shares)   (13,008,000)      
Repurchases of common stock (186,368) $ (13) (186,355)    
Issuance of common stock upon exercise of stock options and (in shares)   379,000      
Issuance of common stock upon exercise of stock options 3,105   3,105    
Net share settlement of equity awards (in shares)   1,827,000      
Net share settlement of equity awards (13,854) $ 3 (13,857)    
Share-based compensation expense 104,003   104,003    
Proceeds from capped call related to extinguishment of 2025 notes 297   297    
Other comprehensive income (loss) 1,062     1,062  
Net (loss) income 8,515       8,515
Ending balance (in shares) at Sep. 30, 2023   115,672,000      
Ending balance at Sep. 30, 2023 1,033,349 $ 116 1,151,697 (56,426) (62,038)
Beginning balance (in shares) at Dec. 31, 2022   126,474,000      
Beginning balance at Dec. 31, 2022 $ 1,116,589 $ 126 1,244,504 (57,488) (70,553)
Ending balance (in shares) at Dec. 31, 2023 102,823,700 102,824,000      
Ending balance at Dec. 31, 2023 $ 944,618 $ 103 1,031,627 (34,739) (52,373)
Beginning balance (in shares) at Jun. 30, 2023   115,178,000      
Beginning balance at Jun. 30, 2023 1,035,001 $ 115 1,121,820 (43,179) (43,755)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of stock options and (in shares)   3,000      
Issuance of common stock upon exercise of stock options 26   26    
Net share settlement of equity awards (in shares)   491,000      
Net share settlement of equity awards (2,788) $ 1 (2,789)    
Share-based compensation expense 32,640   32,640    
Other comprehensive income (loss) (13,247)     (13,247)  
Net (loss) income (18,283)       (18,283)
Ending balance (in shares) at Sep. 30, 2023   115,672,000      
Ending balance at Sep. 30, 2023 $ 1,033,349 $ 116 1,151,697 (56,426) (62,038)
Beginning balance (in shares) at Dec. 31, 2023 102,823,700 102,824,000      
Beginning balance at Dec. 31, 2023 $ 944,618 $ 103 1,031,627 (34,739) (52,373)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchases of common stock (in shares)   (2,116,000)      
Repurchases of common stock (114) $ (2) (112)    
Issuance of common stock upon issuance of ESPP (in shares)   557,000      
Issuance of common stock upon issuance of ESPP 2,188   2,188    
Net share settlement of equity awards (in shares)   2,703,000      
Net share settlement of equity awards (8,645) $ 3 (8,648)    
Share-based compensation expense 73,187   73,187    
Other comprehensive income (loss) 4,690     4,690  
Net (loss) income $ (830,943)       (830,943)
Ending balance (in shares) at Sep. 30, 2024 103,967,436 103,968,000      
Ending balance at Sep. 30, 2024 $ 184,981 $ 104 1,098,242 (30,049) (883,316)
Beginning balance (in shares) at Jun. 30, 2024   103,361,000      
Beginning balance at Jun. 30, 2024 365,500 $ 103 1,075,989 (39,915) (670,677)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net share settlement of equity awards (in shares)   607,000      
Net share settlement of equity awards (822) $ 1 (823)    
Share-based compensation expense 23,076   23,076    
Other comprehensive income (loss) 9,866     9,866  
Net (loss) income $ (212,639)       (212,639)
Ending balance (in shares) at Sep. 30, 2024 103,967,436 103,968,000      
Ending balance at Sep. 30, 2024 $ 184,981 $ 104 $ 1,098,242 $ (30,049) $ (883,316)